Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence
Journal of the American Chemical Society · 08.02.2023 · 145 (5) · 2711-2732
DOI: 10.1021/jacs.2c11098 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Chemical Society, online erschienen am 27.01.2023. Verfasst von Miquel Duran-Frigola und 2 weiteren Autor:innen. Beteiligte Einrichtung: CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: Artificial Intelligence, Multiomics, Proteolysis. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 285 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, H2020 European Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
- Ersilia Open Source Initiative, 28 Belgrave Road, CB1 3DE, Cambridge, United Kingdom.
ORCID-Profile: Georg E Winter
Förderung
- Austrian Science Fund
- H2020 European Research Council
Zitieren
APA
Duran-Frigola, M., Cigler, M., & Winter, G. E. (2023). Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence. Journal of the American Chemical Society, 145(5), 2711-2732. https://doi.org/10.1021/jacs.2c11098
Vancouver
Duran-Frigola M, Cigler M, Winter GE. Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence. Journal of the American Chemical Society. 2023;145(5):2711-2732. doi:10.1021/jacs.2c11098
BibTeX
@article{DuranFrigola2023,
author = {Duran-Frigola, Miquel and Cigler, Marko and Winter, Georg E},
title = {Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence},
journal = {Journal of the American Chemical Society},
year = {2023},
volume = {145},
number = {5},
pages = {2711--2732},
doi = {10.1021/jacs.2c11098}
}
EUVIMED